Biosimilars/follow-on-biologics Market Report

Global and Region Biosimilars/follow-on-biologics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：234
  • REPORT CODE：GMM925680
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Biosimilars/follow-on-biologics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Biosimilars/follow-on-biologicsmarket, defines the market attractiveness level of Biosimilars/follow-on-biologics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Biosimilars/follow-on-biologics industry, describes the types of Biosimilars/follow-on-biologics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biosimilars/follow-on-biologics market and the development prospects and opportunities of Biosimilars/follow-on-biologics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biosimilars/follow-on-biologics market in Chapter 13.

    By Player:

    • Hospira

    • Merck Serono (Merck)

    • Novartis (Sandoz)

    • Teva Pharmaceutical Industries

    • Celltrion Biocon

    • Genentech (Roche)

    • Biogen idec

    • Synthon Pharmaceuticals

    • LG Life Sciences

    By Type:

    • Human growth hormone

    • Erythropoietin

    • Monoclonal antibodies

    • Insulin

    • Interferon

    • Granulocyte-Colony Stimulating Factor

    • Others

    By End-User:

    • Blood disorders

    • Oncology diseases

    • Chronic and autoimmune diseases

    • Growth hormone deficiencies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Biosimilars/follow-on-biologics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Biosimilars/follow-on-biologics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Biosimilars/follow-on-biologics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Biosimilars/follow-on-biologics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Biosimilars/follow-on-biologics Market Analysis and Outlook to 2022

    • 7.1 Global Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 7.2 United States Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 7.3 Europe Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 7.4 China Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 7.5 Japan Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 7.6 India Biosimilars/follow-on-biologics Consumption (2017-2022)

    • 7.7 South Korea Biosimilars/follow-on-biologics Consumption (2017-2022)

    8 Region and Country-wise Biosimilars/follow-on-biologics Market Analysis and Outlook to 2028

    • 8.1 Global Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 8.2 United States Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 8.3 Europe Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 8.4 China Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 8.5 Japan Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 8.6 India Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    • 8.7 South Korea Biosimilars/follow-on-biologics Consumption Forecast (2022-2028)

    9 Global Biosimilars/follow-on-biologics Market Outlook by Types and Applications to 2022

    • 9.1 Global Biosimilars/follow-on-biologics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Human growth hormone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Erythropoietin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Monoclonal antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Interferon Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biosimilars/follow-on-biologics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chronic and autoimmune diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Growth hormone deficiencies Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Biosimilars/follow-on-biologics Market Outlook by Types and Applications to 2028

    • 10.1 Global Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Human growth hormone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Monoclonal antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Interferon Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Blood disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Oncology diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Chronic and autoimmune diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Growth hormone deficiencies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Biosimilars/follow-on-biologics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Biosimilars/follow-on-biologics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Biosimilars/follow-on-biologics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Biosimilars/follow-on-biologics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Biosimilars/follow-on-biologics Market Competitive Analysis

    • 14.1 Hospira

      • 14.1.1 Hospira Company Details

      • 14.1.2 Hospira Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Hospira Biosimilars/follow-on-biologics Product and Service

    • 14.2 Merck Serono (Merck)

      • 14.2.1 Merck Serono (Merck) Company Details

      • 14.2.2 Merck Serono (Merck) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Product and Service

    • 14.3 Novartis (Sandoz)

      • 14.3.1 Novartis (Sandoz) Company Details

      • 14.3.2 Novartis (Sandoz) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Product and Service

    • 14.4 Teva Pharmaceutical Industries

      • 14.4.1 Teva Pharmaceutical Industries Company Details

      • 14.4.2 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product and Service

    • 14.5 Celltrion Biocon

      • 14.5.1 Celltrion Biocon Company Details

      • 14.5.2 Celltrion Biocon Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Product and Service

    • 14.6 Genentech (Roche)

      • 14.6.1 Genentech (Roche) Company Details

      • 14.6.2 Genentech (Roche) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Genentech (Roche) Biosimilars/follow-on-biologics Product and Service

    • 14.7 Biogen idec

      • 14.7.1 Biogen idec Company Details

      • 14.7.2 Biogen idec Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Biogen idec Biosimilars/follow-on-biologics Product and Service

    • 14.8 Synthon Pharmaceuticals

      • 14.8.1 Synthon Pharmaceuticals Company Details

      • 14.8.2 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product and Service

    • 14.9 LG Life Sciences

      • 14.9.1 LG Life Sciences Company Details

      • 14.9.2 LG Life Sciences Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 LG Life Sciences Biosimilars/follow-on-biologics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Biosimilars/follow-on-biologics

    • Figure Biosimilars/follow-on-biologics Picture

    • Table Global Biosimilars/follow-on-biologics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biosimilars/follow-on-biologics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biosimilars/follow-on-biologics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Biosimilars/follow-on-biologics Consumption by Country (2017-2022)

    • Figure United States Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Table Europe Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure China Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Japan Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure India Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biosimilars/follow-on-biologics Consumption and Growth Rate (2017-2022)

    • Figure Global Biosimilars/follow-on-biologics Consumption Forecast by Country (2022-2028)

    • Figure United States Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biosimilars/follow-on-biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human growth hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Consumption and Growth Rate (2017-2022)

    • Figure Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Blood disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic and autoimmune diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Growth hormone deficiencies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Human growth hormone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic and autoimmune diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth hormone deficiencies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Biosimilars/follow-on-biologics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Biosimilars/follow-on-biologics Export by Region (Top 5 Countries) (2017-2028)

    • Table Hospira (Foundation Year, Company Profile and etc.)

    • Table Hospira Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira Biosimilars/follow-on-biologics Product and Service

    • Table Merck Serono (Merck) (Foundation Year, Company Profile and etc.)

    • Table Merck Serono (Merck) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Serono (Merck) Biosimilars/follow-on-biologics Product and Service

    • Table Novartis (Sandoz) (Foundation Year, Company Profile and etc.)

    • Table Novartis (Sandoz) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis (Sandoz) Biosimilars/follow-on-biologics Product and Service

    • Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product and Service

    • Table Celltrion Biocon (Foundation Year, Company Profile and etc.)

    • Table Celltrion Biocon Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Biocon Biosimilars/follow-on-biologics Product and Service

    • Table Genentech (Roche) (Foundation Year, Company Profile and etc.)

    • Table Genentech (Roche) Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech (Roche) Biosimilars/follow-on-biologics Product and Service

    • Table Biogen idec (Foundation Year, Company Profile and etc.)

    • Table Biogen idec Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen idec Biosimilars/follow-on-biologics Product and Service

    • Table Synthon Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product and Service

    • Table LG Life Sciences (Foundation Year, Company Profile and etc.)

    • Table LG Life Sciences Biosimilars/follow-on-biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG Life Sciences Biosimilars/follow-on-biologics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US